You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2009 or most recent year available [see all tables in this series...]

Part (ii) Outpatient clients by primary drug and mean age, gender ratio

Primary drug	Mean age	Gender ratio
Primary drug
Amphetamines	30	2
Ecstasy	26	3

Notes:

Countries providing data: BE, BG, CZ, DK, EE, IE, GR, ES, FR, IT, CY , LU, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, HR.

Data for Poland and Spain refer to 2008.

The number of treatment clients in each country is listed in Table TDI-7.

See also 'General notes for interpreting data’ on the Explanatory notes and help page.

Sources:

Reitox national reports 2010 — Standard table 3. See Table TDI-0 for details on sources. See also TDI-5.

Download this data in Excel (.xls) format

(see the help page for information about formats etc.)